(Q57579927)

English

Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial

scientific article published on 09 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

0 references

phase III clinical trial

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Tadeusz Pieńkowski

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Vladimir Semiglazov

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

5

object named as

Bert Lum

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Gustavo Ismael

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Roberto Hegg

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Susanne Muehlbauer

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Dominik Heinzmann

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sung-Bae Kim

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Mikhail Lichinitser

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Bohuslav Melichar

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Christian Jackisch

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

9 August 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

869-878

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970329-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970329-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970329-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A recombinant human enzyme for enhanced interstitial transport of therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970329-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970329-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parall

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970329-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970329-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970329-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970329-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970329-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetics and pharmacodynamics for treatment optimization in clinical oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970329-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970329-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(12)70329-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22884505%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57579927&oldid=1756754986"